Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 1Phase 1 1

Status

Recruiting 2Withdrawn 1Unknown 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Breast Neoplasms 10184Neoplasms 7810Carcinoma, Non-Small-Cell Lung 5760Prostatic Neoplasms 5024Colorectal Neoplasms 4606Lung Neoplasms 3725Leukemia, Myeloid, Acute 3102Neoplasm Metastasis 3083Multiple Myeloma 3082Pancreatic Neoplasms 2845Melanoma 2653Ovarian Neoplasms 2573Lymphoma 2571Carcinoma, Hepatocellular 2480Stomach Neoplasms 2330Recurrence 2230Head and Neck Neoplasms 2103Precursor Cell Lymphoblastic Leukemia-Lymphoma 2086Lymphoma, Non-Hodgkin 2058Leukemia 2013Brain Neoplasms 1905Glioblastoma 1797Colonic Neoplasms 1791Leukemia, Lymphocytic, Chronic, B-Cell 1771Rectal Neoplasms 1720Uterine Cervical Neoplasms 1693Squamous Cell Carcinoma of Head and Neck 1654Lymphoma, Follicular 1652Lymphoma, Large B-Cell, Diffuse 1597Carcinoma, Renal Cell 1577

Interventions

spartalizumab 1sapropterin 1penpulimab 1niraparib 1anlotinib 1Taxes 1Leucovorin 1Ipilimumab 1IFL protocol 1Gemcitabine 1Decitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × Pancreatic Adenocarcinoma Metastatic × Clear all
NCT07314385 2026-01-02

NH002-mediated Sonoporation With Chemotherapy in Advanced Pancreatic Cancer

National Taiwan University Hospital

Phase 1 Not yet recruiting
24 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma Metastatic

NCT06747845 2025-09-16

ParpVax2

Abramson Cancer Center at Penn Medicine

Phase 2 Recruiting
68 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma Metastatic

NCT05360264 2025-03-24

ORIENTATE

Regina Elena Cancer Institute

Phase 2 Terminated
7 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma Metastatic

NCT06396637 2024-05-02

PD-1 Antibody and Sapropterin Dihydrochloride in Patients With PDAC

Sun Yat-sen University

Phase 2 Unknown
20 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma Metastatic

NCT03127124 2024-04-02

QUILT-2.022 NANT-008 in Combination w/ 5-fluorouracil, Bevacizumab, Leucovorin & Oxaliplatin in Subjects With Pancreatic Cancer

NantPharma, LLC

Phase 1/2 Withdrawn
Gastrointestinal

Pancreatic Adenocarcinoma Metastatic

NCT06051851 2023-09-25

RCT-PAAG

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase 2 Recruiting
177 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡